New P2Y12 inhibitors

被引：9

作者：

Storey, Robert F. ^{[1
]}

机构：

[1] Univ Sheffield, Dept Cardiovasc Sci, Sheffield S10 2RX, S Yorkshire, England

来源：

HEART | 2011年 / 97卷 / 15期

关键词：

ACUTE CORONARY SYNDROMES; OUTCOMES PLATO TRIAL; PLATELET INHIBITION; RECEPTOR ANTAGONIST; DOSE CLOPIDOGREL; TICAGRELOR; INTERVENTION; PRASUGREL; TOLERABILITY; SAFETY;

D O I：

10.1136/hrt.2009.184242

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1262 / 1267

页数：6

共 20 条

[1] Safety, tolerability, and initial efficacy of AZD6140, the first reversivle oral adenosine diphosphate receptor antagonist, compared with clopidigrel, in patients with non-ST-segment elevation acute coronary syndrome - Primary results of the DISPERSE-2 trial [J].

Cannon, Christopher P. ;

Husted, Steen ;

Harrington, Robert A. ;

Scirica, Benjamin M. ;

Emanuelsson, Hakan ;

Storey, Robert F. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (19) :1844-1851

[2] Comparison of ticagrelor with clopidogrel in patients with planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study [J].

Cannon, Christopher P. ;

Harrington, Robert A. ;

James, Stefan ;

Ardissino, Diego ;

Becker, Richard C. ;

Emanuelsson, Hakan ;

Husted, Steen ;

Katus, Hugo ;

Keltai, Matyas ;

Khurmi, Nardev S. ;

Kontny, Frederic ;

Lewis, Basil S. ;

Steg, Philippe Gabriel ;

Storey, Robert F. ;

Wojdyla, Daniel ;

Wallentin, Lars .

LANCET, 2010, 375 (9711) :283-293

[3] Platelet P2Y12 Receptor Influences the Vessel Wall Response to Arterial Injury and Thrombosis [J].

Evans, D. J. W. ;

Jackman, L. E. ;

Chamberlain, J. ;

Crosdale, D. J. ;

Judge, H. M. ;

Jetha, K. ;

Norman, K. E. ;

Francis, S. E. ;

Storey, R. F. .

CIRCULATION, 2009, 119 (01) :116-U236

[4] Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease The ONSET/OFFSET Study [J].

Gurbel, Paul A. ;

Bliden, Kevin P. ;

Butler, Kathleen ;

Tantry, Udaya S. ;

Gesheff, Tania ;

Wei, Cheryl ;

Teng, Renli ;

Antonino, Mark J. ;

Patil, Shankar B. ;

Karunakaran, Arun ;

Kereiakes, Dean J. ;

Parris, Cordel ;

Purdy, Drew ;

Wilson, Vance ;

Ledley, Gary S. ;

Storey, Robert F. .

CIRCULATION, 2009, 120 (25) :2577-U103

[5] Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial [J].

Held, Claes ;

Asenblad, Nils ;

Bassand, Jean Pierre ;

Becker, Richard C. ;

Cannon, Christopher P. ;

Claeys, Marc J. ;

Harrington, Robert A. ;

Horrow, Jay ;

Husted, Steen ;

James, Stefan K. ;

Mahaffey, Kenneth W. ;

Nicolau, Jose C. ;

Scirica, Benjamin M. ;

Storey, Robert F. ;

Vintila, Marius ;

Ycas, Joseph ;

Wallentin, Lars .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (06) :672-684

[6] Prasugrel: A novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile [J].

Jakubowski, Joseph A. ;

Winters, Kenneth J. ;

Naganuma, Hideo ;

Wallentin, Lars .

CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (04) :357-374

[7] Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial [J].

James, Stefan ;

Angiolillo, Dominick J. ;

Cornel, Jan H. ;

Erlinge, David ;

Husted, Steen ;

Kontny, Frederic ;

Maya, Juan ;

Nicolau, Jose C. ;

Spinar, Jindrich ;

Storey, Robert F. ;

Stevens, Susanna R. ;

Wallentin, Lars .

EUROPEAN HEART JOURNAL, 2010, 31 (24) :3006-3016

[8] Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial [J].

James, Stefan ;

Budaj, Andrzej ;

Aylward, Philip ;

Buck, Kristen K. ;

Cannon, Christopher P. ;

Cornel, Jan H. ;

Harrington, Robert A. ;

Horrow, Jay ;

Katus, Hugo ;

Keltai, Matyas ;

Lewis, Basil S. ;

Parikh, Keyur ;

Storey, Robert F. ;

Szummer, Karolina ;

Wojdyla, Daniel ;

Wallentin, Lars .

CIRCULATION, 2010, 122 (11) :1056-1067

[9] Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial [J].

Mehta, Shamir R. ;

Tanguay, Jean-Francois ;

Eikelboom, John W. ;

Jolly, Sanjit S. ;

Joyner, Campbell D. ;

Granger, Christopher B. ;

Faxon, David P. ;

Rupprecht, Hans-Jurgen ;

Budaj, Andrzej ;

Avezum, Alvaro ;

Widimsky, Petr ;

Steg, Philippe Gabriel ;

Bassand, Jean-Pierre ;

Montalescot, Gilles ;

Macaya, Carlos ;

Di Pasquale, Giuseppe ;

Niemela, Kari ;

Ajani, Andrew E. ;

White, Harvey D. ;

Chrolavicius, Susan ;

Gao, Peggy ;

Fox, Keith A. A. ;

Yusuf, Salim .

LANCET, 2010, 376 (9748) :1233-1243

[10] Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis [J].

Steg, Philippe Gabriel ;

James, Stefan ;

Harrington, Robert A. ;

Ardissino, Diego ;

Becker, Richard C. ;

Cannon, Christopher P. ;

Emanuelsson, Hakan ;

Finkelstein, Ariel ;

Husted, Steen ;

Katus, Hugo ;

Kilhamn, Jan ;

Olofsson, Sylvia ;

Storey, Robert F. ;

Weaver, Douglas ;

Wallentin, Lars .

CIRCULATION, 2010, 122 (21) :2131-2141

← 1 2 →